What is Standard Chemical & Pharmaceutical Co EBITDA Margin %?
Standard Chemical & Pharmaceutical CoTPE:1720 95 EBITDA Margin % is 28.51% as of Dec. 2025, which is 13% above its 10-year median of 25.27. GuruFocus rates TPE:1720 with a GF Score™ of 95/100 and a GF Value™ of NT$70.94 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 961 Drug Manufacturers companies, Standard Chemical & Pharmaceutical Co ranks better than 83.04% on this metric.
Standard Chemical & Pharmaceutical Co (TPE:1720) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Standard Chemical & Pharmaceutical Co EBITDA Margin % Related Terms
Standard Chemical & Pharmaceutical Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Standard Chemical & Pharmaceutical Co EBITDA Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Standard Chemical & Pharmaceutical Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Standard Chemical & Pharmaceutical Co EBITDA Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Standard Chemical & Pharmaceutical Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Standard Chemical & Pharmaceutical Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Standard Chemical & Pharmaceutical Co (TPE:1720) has a EBITDA Margin % of 28.51% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Standard Chemical & Pharmaceutical Co and its competitors. This is 13% above median its historical median of 25.27. Over the past decade, Standard Chemical & Pharmaceutical Co's EBITDA Margin % has ranged from 17.88 to 30.15. According to the industry distribution chart, Standard Chemical & Pharmaceutical Co ranks #163 out of 961 companies in the Drug Manufacturers industry, placing it in the top 17%.
Is Standard Chemical & Pharmaceutical Co's EBITDA Margin % too high?
Standard Chemical & Pharmaceutical Co's current EBITDA Margin % of 28.51% is 13% above median its 10-year median of 25.27. Over the past 10 years, this metric has ranged from a low of 17.88 to a high of 30.15. The Drug Manufacturers industry median EBITDA Margin % is 12.49. Standard Chemical & Pharmaceutical Co's value of 28.51% is 128.3% above this industry median. Based on the distribution chart, Standard Chemical & Pharmaceutical Co ranks #163 out of 961 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Standard Chemical & Pharmaceutical Co has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Standard Chemical & Pharmaceutical Co's EBITDA Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Standard Chemical & Pharmaceutical Co ranks #163 out of 961 companies for EBITDA Margin %. This places Standard Chemical & Pharmaceutical Co in the top 17% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 12.49. Standard Chemical & Pharmaceutical Co's value of 28.51% is 128.3% above this benchmark. Historically, Standard Chemical & Pharmaceutical Co's own EBITDA Margin % has ranged from 17.88 to 30.15 over the past decade. While the company's 10-year median is 25.27 vs. the industry median of 12.49, Standard Chemical & Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.49, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Standard Chemical & Pharmaceutical Co's current EBITDA Margin % of 28.51% is 128.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Standard Chemical & Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Standard Chemical & Pharmaceutical Co's current EBITDA Margin % is 28.51%, which is 13% above median its own 10-year median of 25.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Standard Chemical & Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Standard Chemical & Pharmaceutical Co (TPE:1720) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$70.94, compared to a current price of NT$63.90 — trading 9.9% below its estimated fair value. The current EBITDA Margin % is 28.51%, which is 13% above median its 10-year median of 25.27 and 128.3% above the Drug Manufacturers industry median of 12.49. Standard Chemical & Pharmaceutical Co's overall GF Score™ is 95/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Standard Chemical & Pharmaceutical Co (TPE:1720), the current EBITDA Margin % is 28.51% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Standard Chemical & Pharmaceutical Co (TPE:1720) Overvalued in 2026?
Based on GuruFocus' analysis, Standard Chemical & Pharmaceutical Co stock appears to be undervalued.
The current stock price of NT$63.90 is trading 9.9% below its estimated GF Value™ of NT$70.94.
GuruFocus considers Standard Chemical & Pharmaceutical Co to be Modestly Undervalued.
Key valuation signals for TPE:1720:
EBITDA Margin %: 28.51% (13% above median its 10-year median of 25.27)
GF Value™: NT$70.94 vs. price of NT$63.90 (9.9% below fair value)
Industry Position: 128.3% above the Drug Manufacturers median (#163 of 961)
No single metric tells the full story. See the TPE:1720 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Standard Chemical & Pharmaceutical Co Business Description
Standard Chemical & Pharmaceutical Co Ltd is engaged in the manufacturing and sales of Chinese and western medicine, cosmetics, beverage, normal instruments and medical instruments. Its segments include Medicine, Dietary supplement and Ingredients. The majority of the revenue is derived from the Medicine segment. Geographically it operates in Taiwan, Japan and Others with Taiwan generating the maximum revenue.
95GF Score
Get the complete analysis for TPE:1720
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1720 has been successfully added to your 
